ProPerma™ Oral Formulation Technology


ProPerma™ uniquely improves both permeability and bioavailability of BCS III and BCS IV compounds by deploying an innovative and bespoke combination of GRAS and novel enhancing excipients. Our “formulation toolbox” of excipients falls within the pharmaceutically accepted domain. Unlike other technologies, ProPerma™ improves both permeability and bioavailability by deploying a smart combination of pH-lowering, membrane wetting, charge dispersal and solubilizing agents without making physicochemical modifications to the partner’s API.

Download our ProPerma™ brochure to learn how Enteris BioPharma can solve your oral formulation challenges.